JCAD Promotes Progression of Nonalcoholic Steatohepatitis to Liver Cancer by Inhibiting LATS2 Kinase Activity
Authors:
Open Access
- 1 October 2017
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 77 (19) , 5287-5300
Abstract
Nonalcoholic steatohepatitis-associated hepatocellular carcinoma (NASH-HCC) is a malignancy whose incidents are rapidly increasing. However, the mechanisms that drive development of HCC in a steatotic microenvironment remain unknown. Here we report that the obesity-associated protein JCAD is expressed at significantly higher levels in human NASH-HCC specimens compared with pericarcinoma specimens. High JCAD expression was verified in multiple hepatoma cell lines. Forced overexpression of JCAD in hepatoma cells promoted tumor growth and proliferation, whereas JCAD silencing yielded opposite effects. JCAD interacted with the kinase domain of the tumor suppressor kinase LATS2, a core component of the Hippo signaling pathway. JCAD overexpression inhibited the ability of LATS2 to phosphorylate YAP in this pathway, in turn upregulating CCND1 and GLI2 to promote hepatoma cell proliferation. JCAD was induced by fatty acid overload in hepatic cells and was highly expressed in a mouse model of NASH-precarcinoma lesions, where the ratio of phospho-YAP to YAP was decreased. In human NASH-HCC specimens, JCAD expression and YAP phosphorylation patterns paralleled with the mouse model. Our findings illuminate a new role for JCAD and its critical interplay in the Hippo signaling cascade during the transition of NASH to HCC, with potential implications for therapeutic development in this setting. Cancer Res; 77(19); 5287–300. ©2017 AACR.Keywords
All Related Versions
Funding Information
- National Natural Science Foundation (81272436, 81572356, 2016YFE0107400)
- Ministry of Science and Technology of China (81272725 and 81530077)
This publication has 36 references indexed in Scilit:
- LKB1 tumor suppressor regulates AMP kinase/mTOR-independent cell growth and proliferation via the phosphorylation of YapOncogene, 2012
- Angiomotin family proteins are novel activators of the LATS2 kinase tumor suppressorMolecular Biology of the Cell, 2011
- Epithelial mesenchymal transition and hedgehog signaling activation are associated with chemoresistance and invasion of hepatoma subpopulationsJournal of Hepatology, 2011
- A coronary artery disease-associated gene product, JCAD/KIAA1462, is a novel component of endothelial cell–cell junctionsBiochemical and Biophysical Research Communications, 2011
- A genome-wide association study in Europeans and South Asians identifies five new loci for coronary artery diseaseNature Genetics, 2011
- LATS2 Is a Tumor Suppressor Gene of Malignant MesotheliomaCancer Research, 2011
- Genome-wide association study identifies a new locus for coronary artery disease on chromosome 10p11.23European Heart Journal, 2010
- LATS2 is De-methylated and Overexpressed in Nasopharyngeal Carcinoma and Predicts Poor PrognosisBMC Cancer, 2010
- The Hippo Signaling Pathway in Development and CancerDevelopmental Cell, 2010
- Elucidation of a Universal Size-Control Mechanism in Drosophila and MammalsCell, 2007